Decoded – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

Decoded

Dr. Jurgi Camblong

Health & Fitness

Science

Technology

Frequency: 1 episode/32d. Total Eps: 13

Decoded is the podcast hosted by Dr. Jurgi Camblong - Founder and Executive Chairman of the Board of SOPHiA GENETICS, molecular biologist, and global leader and pioneer of data-driven medicine.

In each episode, he connects with world-class scientists, clinicians, innovators, and policymakers to uncover how data, technology, and clinical expertise converge to transform care.

From accelerating cancer diagnostics to transforming the understanding of rare and inherited disorders, Decoded goes beyond the buzz to reveal how innovation translates into real outcomes for patients worldwide.

With a sharp focus on multimodal data, AI in healthcare, and global equal access to patient care, Decoded goes beyond theory to decode what’s working - and what it takes to scale innovation that truly improves lives.

Read moreCollapse

Site

RSS

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

No recent rankings available

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 59%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

The DNA of Discovery

Friday, November 7, 2025 • Duration 30:12

In this episode, Dr. Jurgi Camblong travels to the University of Oxford to meet Professor Nicholas Proudfoot, one of the true pioneers of molecular biology.

For more than five decades, Nick has helped decode life itself, revealing how genes are turned on and off, how RNA carries meaning beyond proteins, and how curiosity can drive discoveries that last a lifetime.

Together, they revisit the early days of modern biology - a time before PCR or cloning - and trace how one generation of scientists transformed trial and error into the precision science we know today.

From the discovery of the AAUAAA “full stop” that signals where genes end, to showing how DNA loops connect beginnings and endings, this is the story of how the foundations of modern genetics were built, one question at a time.

You’ll hear about:

• The birth of molecular biology, from improvisation to innovation.
• The hidden power of noncoding RNAs and gene regulation.
• The beauty and necessity of curiosity-driven research.
• Why protecting fundamental science matters more than ever.

Recorded in Oxford, this episode is a love letter to discovery - and to the mentors who remind us that innovation starts with a simple question: why?

“All great discoveries begin with curiosity.
If we stop funding curiosity-driven science,
we stop funding the foundation of tomorrow’s medicine.”
— Professor Nicholas Proudfoot, University of Oxford

Read moreCollapse

AI Adoption at Scale: Real-World Impact in Healthcare

Tuesday, October 14, 2025 • Duration 31:37

A Conversation with Parminder Bhatia, Chief AI Officer, GE HealthCare

After three episodes with leaders in oncology and medicine - Prof. Malapelle (International Society of Liquid Biopsy), Dr. David Rhew (Microsoft), and Dr. Pedram Razavi (MSK), Jurgi turns to the question everyone’s asking:

How do we move from impressive demos to real impact at the bedside—at scale?

In this episode, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Parminder “Parry” Bhatia, Chief AI Officer at GE HealthCare, to unpack the hard parts of AI in medicine: earning clinical trust, fitting into workflows, proving value, and scaling safely across complex systems.

You’ll hear about:

• Adoption as the KPI
• The validation moat - building clinical-grade trust, calibration, and governance.
• Foundation models in imaging
• Real impact of AI in healthcare
• What’s next - agentic AI for tumor-board style decision support, and training clinicians to treat AI like a co-pilot they can question.

If you’re investing in, building, or deploying clinical AI, this is the playbook teams will be sharing. Listen on Spotify or Apple Podcasts.

Read moreCollapse

Rethinking Cancer Through AI and Precision Medicine with Dr. Pedram Razavi, Memorial Sloan Kettering Cancer Center

Monday, September 22, 2025 • Duration 37:25

Cancer has been described for a long time, yet only now are we beginning to truly decode it.

In this episode of Decoded, Dr. Jurgi Camblong, Founder of SOPHiA GENETICS, speaks with Dr. Pedram Razavi, Director of Liquid Biopsy and Cancer Genomics at Memorial Sloan Kettering Cancer Center.

From the first historical mentions of tumors to today’s breakthroughs in precision oncology, Dr. Razavi shares how genomics, liquid biopsy, and AI are reshaping the way we detect, treat, and even think about cancer. Along the way, Dr. Razavi shares personal stories - the human moments that drive discovery.

In this exciting episode of Decoded, you'll hear:

• The evolving definition of cancer - what makes cancer “selfish,” and why some tumors adapt
• How breast oncology helped pioneer precision medicine
• Why liquid biopsy may let us anticipate resistance before it appears
• The art of oncology: data, science, and the patient in front of you

This conversation bridges history, science, and the future - for clinicians and researchers, patients and families, and anyone who wants to understand how cancer care is changing.

Read moreCollapse

Transforming Healthcare with Responsible AI: A Conversation with David Rhew, Microsoft’s Global Chief Medical Officer

Monday, July 21, 2025 • Duration 36:00

In this episode of Decoded, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Dr. David Rhew, Global Chief Medical Officer at Microsoft and adjunct professor at Stanford University, to explore how responsible AI, multimodal data, and collective intelligence are reshaping global healthcare.

From his early fascination with arcade games to his leadership at Microsoft, Dr. Rhew shares a unique journey that blends computer science, clinical practice, and visionary health technology.

Together, they explore:

Why building trust in AI is fundamental to healthcare transformation
What multimodal data means for personalized, predictive medicine
How technology can drive equity and scale across underserved regions
The cultural and regulatory barriers that still stand in the way

Dr. Rhew also offers timely insights on what the next decade holds for diagnostics, prescribing, and healthcare collaboration - and his advice for the next generation of innovators in technology and medicine.

This is a candid, visionary conversation about the future of care: data-powered, human-centered, and globally connected.

Read moreCollapse

Liquid Biopsy Decoded: Data, Diagnostics, and the Future of Cancer Care

Monday, June 23, 2025 • Duration 23:45

How do we move from discovery to action in the fight against cancer?

In this inaugural episode of the Decoded podcast, Dr. Jurgi Camblong speaks with Professor Umberto Malapelle, one of the leading voices in molecular diagnostics and liquid biopsy, to explore how precision data is reshaping the fight against cancer.

Together, they decode the evolving role of pathology, tracing the shift from glass slides to genomic signals and the rise of liquid biopsy as a dynamic, non-invasive tool in cancer care.

Professor Malapelle reveals how integrating molecular insights is making diagnostics more precise, accessible, and equitable - while empowering clinicians to personalize treatment at scale.

The conversation unpacks the real-world impact of liquid biopsy, the economics of molecular testing, and why the future of cancer care depends on both collaboration and a new generation of digitally fluent healthcare professionals.

Listen in for:

Insights on where cancer diagnostics is heading
The power - and challenge - of integrating complex data in medicine
Why liquid biopsy is more than a buzzword

This is the future of oncology, decoded.

Explore more: https://www.sophiagenetics.com/podcasts/

Read moreCollapse

The Pioneer of the Cloud

Wednesday, June 10, 2026 • Duration 27:08

What does it take to ask one question — *how do you free software from hardware?* — and end up reshaping the entire computing industry? In this episode of Decoded, Dr. Jurgi Camblong speaks with Edouard Bugnion, co-founder of VMware and Vice President for Innovation and Impact at EPFL, the Swiss Federal Institute of Technology in Lausanne. VMware didn't just build a product. It built the foundation on which the modern cloud was built — and was acquired by Broadcom in 2023 for $69 billion. From a childhood in Neuchâtel to a PhD at Stanford, from research lab to billion-dollar company, and back to Switzerland as a professor and public advisor, Edouard has spent his career at the precise intersection of deep science and real-world impact. You'll hear how a single idea about separating software from hardware gave birth to an industry, what the dot-com crash taught him about building through uncertainty, the three factors he believes determine whether a company succeeds or fails, why the energy cost of AI is a problem that can't be wished away, and what it actually means to be responsible when innovation moves faster than society can keep up. This episode is about what happens when a scientist becomes a builder, and why the most important question in technology right now may not be *what can AI do* — but *what should it do.*

Read moreCollapse

Building Global Tech from Europe: The VC Playbook

Wednesday, May 6, 2026 • Duration 24:08

What does it take to turn a two-person startup in Paris into a $6.8 billion exit, and then do it all over again for 200 other founders?

In this episode of Decoded, Dr. Jurgi Camblong speaks with Bernard Liautaud, co-founder of BusinessObjects and Managing Partner at Balderton Capital, one of Europe's leading venture capital firms backing category-defining companies like Revolut, Wayve, and Quantum Systems.

Bernard didn't just build a company. He built a category. Starting with two people in Paris in 1990, he helped define what business intelligence could be, took the company to NASDAQ, and sold it to SAP for $6.8 billion. Then he turned that experience into fuel for the next generation of European founders.

You'll hear why Europe's VC returns have quietly outperformed the US, how Balderton evaluates founders and the one trait they call "insurgency," what the story of Revolut reveals about the power of execution, why Bernard believes Europe has not just the talent but the values to build AI responsibly, and the philosophy behind his most personal insight: as a VC, you have many shots. As a founder, you have one.

This episode is about what happens when ambition meets experience, and why Europe's most exciting chapter may still be ahead of us.

Read moreCollapse

How to Accelerate the Future of Oncology with Keith Flaherty, President of the AACR

Thursday, April 9, 2026 • Duration 38:18

What happens when a world-class biologist decides that academic research isn't moving fast enough for patients?

Dr. Keith Flaherty is a physician, scientist, and founder who obsesses over the "wiring of cells". As the Director of Clinical Research at the Mass General Hospital Cancer Center and a Professor of Medicine at Harvard Medical School, he has authored over 300 peer-reviewed research publications. But he didn't stop at academia. He went on to co-found Loxo Oncology and Scorpion Therapeutics, driving billions in acquisitions and fundamentally changing precision cancer care.

In this episode, Keith joins Dr. Jurgi Camblong to discuss his journey from early cell biology to becoming president of the AACR. They explore the evolution of melanoma treatments, the mechanics of targeted inhibitors, and the friction in the system that prevents us from learning from every patient.

Because better outcomes don’t come from better science alone. They come from making the whole system work.

#Oncology #PrecisionMedicine #AACR #DrugDevelopment #DecodedPodcast

Read moreCollapse

From Mars Rovers to Medicine: The AI Revolution with Thomas Fuchs, Chief AI Officer, Eli Lilly

Tuesday, March 10, 2026 • Duration 29:53

What happens when the mind behind the Mars Rovers turns its attention to fighting cancer and developing next-generation medicines?
Today, Thomas Fuchs is the Chief AI Officer at Eli Lilly & Company, but he started his career at NASA, building the AI that helped rovers navigate the surface of Mars. He soon realized that the same math used to distinguish sand from rocks could be used to identify cancer cells on a pathology slide. He transitioned to healthcare, coined the term "computational pathology", and secured the first-ever FDA approval for an AI solution in cancer pathology after founding Paige.ai.
In this episode, Thomas joins Dr. Jurgi Camblong to discuss his journey, including how to build trust around AI, the massive potential of the technology for medicine discovery, and what the future holds for medicine.

Because better outcomes don’t come from better algorithms alone—they come from pioneers brave enough to trust them.

For more information on this episode follow the link below:
https://www.linkedin.com/in/jurgicamblong/
https://www.sophiagenetics.com/podcasts/

#AIinHealthcare #DrugDiscovery #GenerativeAI #EliLilly #DecodedPodcast

Read moreCollapse

The Tumor Hacker: How Data & AI Are Rewriting the Future of Oncology

Tuesday, February 10, 2026 • Duration 27:17

Most doctors look at a tumor and see a disease. Professor Olivier Michielin sees a code waiting to be cracked.

Starting his career in physics and training under Nobel Prize winner Martin Karplus, Olivier realized early on that he "would not be happy just talking to electrons". He pivoted to medicine to bring a data-driven, engineering mindset to oncology. Today, he is rewriting the rules of how we treat melanoma and other complex cancers by combining immunotherapy with advanced algorithms.

In this episode, the "Tumor Hacker" joins Dr. Jurgi Camblong to discuss how he is using physics, AI, and immunotherapy to rewrite the future of oncology. From training with Nobel laureates to leading oncology at HUG, Olivier explains why the future of medicine isn’t about discovering cures by accident - it’s about engineering them by design.

A conversation about the convergence of data, biology, and the human immune system.

For more information on this episode follow the link below:

https://www.linkedin.com/in/jurgicamblong/
https://www.sophiagenetics.com/podcasts/

#Oncology #Immunotherapy #AIinHealthcare #PrecisionMedicine #DecodedPodcast

Read moreCollapse

Decoded – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Decoded – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

LinkedIn3

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

LinkedIn3

Other2

Buzzsprout1